메뉴 건너뛰기




Volumn 10, Issue 2, 2015, Pages 281-292

Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids

Author keywords

Cannabidiol; Cannabinoid; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroprotection; 9 tetrahydrocannabinol

Indexed keywords

CANNABINOID; CANNABIS; ENDOCANNABINOID; PLACEBO; SODIUM CHANNEL BLOCKING AGENT; TETRAHYDROCANNABINOL; VOLTAGE GATED SODIUM CHANNEL; DRONABINOL; MEDICAL CANNABIS; NEUROPROTECTIVE AGENT;

EID: 84931009752     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-014-9575-8     Document Type: Review
Times cited : (46)

References (81)
  • 1
    • 80054714639 scopus 로고    scopus 로고
    • Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse
    • Al-Izki S, Pryce G, O’Neill JK, Butter C, Giovannoni G, Amor S, Baker D (2012) Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. Mult Scler Rel Dis 1:29–38
    • (2012) Mult Scler Rel Dis , vol.1 , pp. 29-38
    • Al-Izki, S.1    Pryce, G.2    O’Neill, J.K.3    Butter, C.4    Giovannoni, G.5    Amor, S.6    Baker, D.7
  • 3
    • 84856808348 scopus 로고    scopus 로고
    • Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis
    • COI: 1:CAS:528:DC%2BC38XitlKntb8%3D, PID: 22119102
    • Baker D, Amor S (2012) Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis. J Neuroimmunol 242:78–83
    • (2012) J Neuroimmunol , vol.242 , pp. 78-83
    • Baker, D.1    Amor, S.2
  • 4
    • 84906318531 scopus 로고    scopus 로고
    • Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely
    • Baker D, Amor S (2014) Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely. Mult Scler Rel Dis 3:555–564
    • (2014) Mult Scler Rel Dis , vol.3 , pp. 555-564
    • Baker, D.1    Amor, S.2
  • 5
    • 0034594905 scopus 로고    scopus 로고
    • Cannabinoids control spasticity and tremor in a multiple sclerosis model
    • COI: 1:CAS:528:DC%2BD3cXhvVyqsb4%3D, PID: 10716447
    • Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404:84–87
    • (2000) Nature , vol.404 , pp. 84-87
    • Baker, D.1    Pryce, G.2    Croxford, J.L.3    Brown, P.4    Pertwee, R.G.5    Huffman, J.W.6    Layward, L.7
  • 6
    • 79959476848 scopus 로고    scopus 로고
    • Critical appraisal of animal models of multiple sclerosis
    • PID: 21372117
    • Baker D, Gerritsen W, Rundle J, Amor S (2011) Critical appraisal of animal models of multiple sclerosis. Mult Scler 17:647–657
    • (2011) Mult Scler , vol.17 , pp. 647-657
    • Baker, D.1    Gerritsen, W.2    Rundle, J.3    Amor, S.4
  • 7
    • 84857791339 scopus 로고    scopus 로고
    • The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
    • COI: 1:CAS:528:DC%2BC38XptF2rt7w%3D
    • Baker D, Pryce G, Jackson SJ, Bolton C, Giovannoni G (2012) The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis. Mult Scler Rel Dis 1:64–75
    • (2012) Mult Scler Rel Dis , vol.1 , pp. 64-75
    • Baker, D.1    Pryce, G.2    Jackson, S.J.3    Bolton, C.4    Giovannoni, G.5
  • 9
    • 0030793625 scopus 로고    scopus 로고
    • Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids
    • COI: 1:CAS:528:DyaK2sXmt1Sqsbc%3D, PID: 9303334
    • Bolton C, O’Neill JK, Allen SJ, Baker D (1997) Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids. Int Arch Allergy Immunol 114:74–80
    • (1997) Int Arch Allergy Immunol , vol.114 , pp. 74-80
    • Bolton, C.1    O’Neill, J.K.2    Allen, S.J.3    Baker, D.4
  • 10
    • 79959684881 scopus 로고    scopus 로고
    • Heterogeneity in the composition of marijuana seized in California
    • COI: 1:CAS:528:DC%2BC3MXosVGrs78%3D, PID: 21288662
    • Burgdorf JR, Kilmer B, Pacula RL (2011) Heterogeneity in the composition of marijuana seized in California. Drug Alcohol Depend 117:59–61
    • (2011) Drug Alcohol Depend , vol.117 , pp. 59-61
    • Burgdorf, J.R.1    Kilmer, B.2    Pacula, R.L.3
  • 11
    • 84866451855 scopus 로고    scopus 로고
    • Δ9-tetrahydrocannabinol (Δ9-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease
    • COI: 1:CAS:528:DC%2BC38Xhtl2qsb3L, PID: 22236282
    • Carroll CB, Zeissler ML, Hanemann CO, Zajicek JP (2012) Δ9-tetrahydrocannabinol (Δ9-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease. Neuropathol Appl Neurobiol 38:535–547
    • (2012) Neuropathol Appl Neurobiol , vol.38 , pp. 535-547
    • Carroll, C.B.1    Zeissler, M.L.2    Hanemann, C.O.3    Zajicek, J.P.4
  • 12
    • 34250635495 scopus 로고    scopus 로고
    • Cannabis use in patients with multiple sclerosis
    • COI: 1:STN:280:DC%2BD28nltleksw%3D%3D, PID: 17086912
    • Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (2006) Cannabis use in patients with multiple sclerosis. Mult Scler 12:646–651
    • (2006) Mult Scler , vol.12 , pp. 646-651
    • Chong, M.S.1    Wolff, K.2    Wise, K.3    Tanton, C.4    Winstock, A.5    Silber, E.6
  • 13
    • 2942615466 scopus 로고    scopus 로고
    • Patterns of cannabis use among patients with multiple sclerosis
    • COI: 1:STN:280:DC%2BD2c3osVCluw%3D%3D, PID: 15184623
    • Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME (2004) Patterns of cannabis use among patients with multiple sclerosis. Neurology 62:2098–2100
    • (2004) Neurology , vol.62 , pp. 2098-2100
    • Clark, A.J.1    Ware, M.A.2    Yazer, E.3    Murray, T.J.4    Lynch, M.E.5
  • 14
    • 0037029424 scopus 로고    scopus 로고
    • Multiple sclerosis
    • PID: 11955556
    • Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231
    • (2002) Lancet , vol.359 , pp. 1221-1231
    • Compston, A.1    Coles, A.2
  • 15
    • 54149084585 scopus 로고    scopus 로고
    • Multiple sclerosis
    • COI: 1:CAS:528:DC%2BD1cXht12gtLvN, PID: 18970977
    • Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517
    • (2008) Lancet , vol.372 , pp. 1502-1517
    • Compston, A.1    Coles, A.2
  • 16
    • 0030740514 scopus 로고    scopus 로고
    • The perceived effects of smoked cannabis on patients with multiple sclerosis
    • COI: 1:STN:280:DyaK2szps1Khtw%3D%3D, PID: 9252798
    • Consroe P, Musty R, Rein J, Tillery W, Pertwee R (1997) The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 38:44–48
    • (1997) Eur Neurol , vol.38 , pp. 44-48
    • Consroe, P.1    Musty, R.2    Rein, J.3    Tillery, W.4    Pertwee, R.5
  • 17
    • 84863645307 scopus 로고    scopus 로고
    • Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
    • PID: 22586334
    • Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B (2012) Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ 184:1143–1150
    • (2012) CMAJ , vol.184 , pp. 1143-1150
    • Corey-Bloom, J.1    Wolfson, T.2    Gamst, A.3    Jin, S.4    Marcotte, T.D.5    Bentley, H.6    Gouaux, B.7
  • 18
    • 56649092813 scopus 로고    scopus 로고
    • A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells
    • COI: 1:CAS:528:DC%2BD1cXhsVGhurfJ, PID: 18848818
    • Correa F, Docagne F, Mestre L, Clemente D, Hernangómez M, Loría F, Guaza C (2009) A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochem Pharmacol 77:86–100
    • (2009) Biochem Pharmacol , vol.77 , pp. 86-100
    • Correa, F.1    Docagne, F.2    Mestre, L.3    Clemente, D.4    Hernangómez, M.5    Loría, F.6    Guaza, C.7
  • 19
    • 37749034365 scopus 로고    scopus 로고
    • Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis
    • COI: 1:CAS:528:DC%2BD1cXlvVGisw%3D%3D, PID: 18037503
    • Croxford JL, Pryce G, Jackson SJ, Ledent C, Giovannoni G, Pertwee RG, Yamamura T, Baker D (2008) Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. J Neuroimmunol 193:120–129
    • (2008) J Neuroimmunol , vol.193 , pp. 120-129
    • Croxford, J.L.1    Pryce, G.2    Jackson, S.J.3    Ledent, C.4    Giovannoni, G.5    Pertwee, R.G.6    Yamamura, T.7    Baker, D.8
  • 20
    • 0017227448 scopus 로고
    • Influence of cannabidiol on delta-9-tetrahydrocannabinol effects
    • COI: 1:CAS:528:DyaE28XhsVCqu7g%3D, PID: 770048
    • Dalton WS, Martz R, Lemberger L, Rodda BE, Forney RB (1976) Influence of cannabidiol on delta-9-tetrahydrocannabinol effects. Clin Pharmacol Ther 19:300–309
    • (1976) Clin Pharmacol Ther , vol.19 , pp. 300-309
    • Dalton, W.S.1    Martz, R.2    Lemberger, L.3    Rodda, B.E.4    Forney, R.B.5
  • 21
    • 84859111260 scopus 로고    scopus 로고
    • Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
    • PID: 22342378
    • de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J (2012) Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. Neuropharmacology 62:2299–2308
    • (2012) Neuropharmacology , vol.62 , pp. 2299-2308
    • de Lago, E.1    Moreno-Martet, M.2    Cabranes, A.3    Ramos, J.A.4    Fernández-Ruiz, J.5
  • 22
    • 33947583201 scopus 로고    scopus 로고
    • Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoidsthrough CB1 and CB2 receptor activation
    • COI: 1:CAS:528:DC%2BD2sXjslGrsbk%3D, PID: 17229577
    • Docagne F, Muñetón V, Clemente D, Ali C, Loría F, Correa F, Hernangómez M, Mestre L, Vivien D, Guaza C (2007) Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoidsthrough CB1 and CB2 receptor activation. Mol Cell Neurosci 34:551–561
    • (2007) Mol Cell Neurosci , vol.34 , pp. 551-561
    • Docagne, F.1    Muñetón, V.2    Clemente, D.3    Ali, C.4    Loría, F.5    Correa, F.6    Hernangómez, M.7    Mestre, L.8    Vivien, D.9    Guaza, C.10
  • 24
    • 0142151067 scopus 로고    scopus 로고
    • Neuroprotective effect of (−)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite
    • COI: 1:CAS:528:DC%2BD3sXpsVWltbc%3D, PID: 14578199
    • El-Remessy AB, Khalil IE, Matragoon S, Abou-Mohamed G, Tsai NJ, Roon P, Caldwell RB, Caldwell RW, Green K, Liou GI (2003) Neuroprotective effect of (−)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 163:1997–2008
    • (2003) Am J Pathol , vol.163 , pp. 1997-2008
    • El-Remessy, A.B.1    Khalil, I.E.2    Matragoon, S.3    Abou-Mohamed, G.4    Tsai, N.J.5    Roon, P.6    Caldwell, R.B.7    Caldwell, R.W.8    Green, K.9    Liou, G.I.10
  • 25
    • 0033621602 scopus 로고    scopus 로고
    • Potency trends of delta9-Δ9-THC and other cannabinoids in confiscated marijuana from 1980–1997
    • COI: 1:CAS:528:DC%2BD3cXktVGkur4%3D, PID: 10641915
    • ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF (2000) Potency trends of delta9-Δ9-THC and other cannabinoids in confiscated marijuana from 1980–1997. J Forensic Sci 45:24–30
    • (2000) J Forensic Sci , vol.45 , pp. 24-30
    • ElSohly, M.A.1    Ross, S.A.2    Mehmedic, Z.3    Arafat, R.4    Yi, B.5    Banahan, B.F.6
  • 26
    • 84883026511 scopus 로고    scopus 로고
    • Motor effects of the non-psychotropic phytocannabinoidcannabidiol that are mediated by 5-HT1A receptors
    • COI: 1:CAS:528:DC%2BC3sXhvFylurzF, PID: 23924692
    • Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C (2013) Motor effects of the non-psychotropic phytocannabinoidcannabidiol that are mediated by 5-HT1A receptors. Neuropharmacology 75:155–163
    • (2013) Neuropharmacology , vol.75 , pp. 155-163
    • Espejo-Porras, F.1    Fernández-Ruiz, J.2    Pertwee, R.G.3    Mechoulam, R.4    García, C.5
  • 27
  • 28
    • 0036143998 scopus 로고    scopus 로고
    • Soluble guanylylcyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition
    • COI: 1:CAS:528:DC%2BD38XltlWj, PID: 11752210
    • Garthwaite G, Goodwin DA, Neale S, Riddall D, Garthwaite J (2002) Soluble guanylylcyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition. Mol Pharmacol 61:97–104
    • (2002) Mol Pharmacol , vol.61 , pp. 97-104
    • Garthwaite, G.1    Goodwin, D.A.2    Neale, S.3    Riddall, D.4    Garthwaite, J.5
  • 29
    • 84920674917 scopus 로고    scopus 로고
    • The problems with repurposing: is there really an alternative to ‘Big Pharma’ for developing new drugs for MS? Mult Scler Rel Dis
    • Giovannoni G, Baker D, Schmierer K (2015) The problems with repurposing: is there really an alternative to ‘Big Pharma’ for developing new drugs for MS? Mult Scler Rel Dis. doi:10.1016/j.msard.2014.11.005
    • (2015) doi:10.1016/j.msard.2014.11.005
    • Giovannoni, G.1    Baker, D.2    Schmierer, K.3
  • 32
    • 0032493197 scopus 로고    scopus 로고
    • Cannabidiol and (−)Delta9-tetrahydrocannabinol are neuroprotective antioxidants
    • COI: 1:CAS:528:DyaK1cXks1SltL0%3D, PID: 9653176
    • Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (−)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A 95:8268–8273
    • (1998) Proc Natl Acad Sci U S A , vol.95 , pp. 8268-8273
    • Hampson, A.J.1    Grimaldi, M.2    Axelrod, J.3    Wink, D.4
  • 33
    • 77950106481 scopus 로고    scopus 로고
    • Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis
    • COI: 1:CAS:528:DC%2BC3cXjslShtb8%3D, PID: 20203531
    • Hasseldam H, Johansen FF (2010) Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis. Neuroimmunomodulation 17:252–264
    • (2010) Neuroimmunomodulation , vol.17 , pp. 252-264
    • Hasseldam, H.1    Johansen, F.F.2
  • 34
  • 36
    • 84897860455 scopus 로고    scopus 로고
    • Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se
    • COI: 1:CAS:528:DC%2BC2cXmt1Wkurg%3D, PID: 24642454
    • Hill AJ, Jones NA, Smith I, Hill CL, Williams CM, Stephens GJ, Whalley BJ (2014) Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. Neurosci Lett 566:269–274
    • (2014) Neurosci Lett , vol.566 , pp. 269-274
    • Hill, A.J.1    Jones, N.A.2    Smith, I.3    Hill, C.L.4    Williams, C.M.5    Stephens, G.J.6    Whalley, B.J.7
  • 38
    • 84912567630 scopus 로고    scopus 로고
    • The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability
    • COI: 1:CAS:528:DC%2BC2cXhtFGms7zI, PID: 25029033
    • Iannotti FA, Hill CL, Leo A, Alhusaini A, Soubrane C, Mazzarella E, Russo E, Whalley BJ, Di Marzo V, Stephens GJ (2014) The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci 5:1131–1141
    • (2014) ACS Chem Neurosci , vol.5 , pp. 1131-1141
    • Iannotti, F.A.1    Hill, C.L.2    Leo, A.3    Alhusaini, A.4    Soubrane, C.5    Mazzarella, E.6    Russo, E.7    Whalley, B.J.8    Di Marzo, V.9    Stephens, G.J.10
  • 39
    • 77953476309 scopus 로고    scopus 로고
    • Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
    • COI: 1:CAS:528:DC%2BC3cXpsFajur4%3D, PID: 20621711
    • Kapoor R, Furby J, Hayton T, Smith KJ, Altmann DR, Brenner R, Chataway J, Hughes RA, Miller DH (2010) Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol 9:681–688
    • (2010) Lancet Neurol , vol.9 , pp. 681-688
    • Kapoor, R.1    Furby, J.2    Hayton, T.3    Smith, K.J.4    Altmann, D.R.5    Brenner, R.6    Chataway, J.7    Hughes, R.A.8    Miller, D.H.9
  • 40
    • 20444487825 scopus 로고    scopus 로고
    • Cannabinoid influence on cytokine profile in multiple sclerosis
    • COI: 1:CAS:528:DC%2BD2MXlvFOit7s%3D, PID: 15932522
    • Katona S, Kaminski E, Sanders H, Zajicek J (2005) Cannabinoid influence on cytokine profile in multiple sclerosis. Clin Exp Immunol 140:580–585
    • (2005) Clin Exp Immunol , vol.140 , pp. 580-585
    • Katona, S.1    Kaminski, E.2    Sanders, H.3    Zajicek, J.4
  • 42
    • 79960293903 scopus 로고    scopus 로고
    • Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
    • Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben-Nun A, Juknat A, Vogel Z (2011) Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol 16:1507–1519
    • (2011) Br J Pharmacol , vol.16 , pp. 1507-1519
    • Kozela, E.1    Lev, N.2    Kaushansky, N.3    Eilam, R.4    Rimmerman, N.5    Levy, R.6    Ben-Nun, A.7    Juknat, A.8    Vogel, Z.9
  • 43
    • 84876488583 scopus 로고    scopus 로고
    • A double-blind, randomized, placebo-controlled, parallel-group study of Δ9-THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
    • COI: 1:CAS:528:DC%2BC3sXlsF2ms7s%3D, PID: 23180178
    • Langford RM, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, Ratcliffe S (2013) A double-blind, randomized, placebo-controlled, parallel-group study of Δ9-THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. J Neurol 260:984–997
    • (2013) J Neurol , vol.260 , pp. 984-997
    • Langford, R.M.1    Mares, J.2    Novotna, A.3    Vachova, M.4    Novakova, I.5    Notcutt, W.6    Ratcliffe, S.7
  • 44
    • 77954382272 scopus 로고    scopus 로고
    • Evidence for a two-stage disability progression in multiple sclerosis
    • PID: 20423930
    • Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J, Edan G (2010) Evidence for a two-stage disability progression in multiple sclerosis. Brain 133:1900–1913
    • (2010) Brain , vol.133 , pp. 1900-1913
    • Leray, E.1    Yaouanq, J.2    Le Page, E.3    Coustans, M.4    Laplaud, D.5    Oger, J.6    Edan, G.7
  • 45
    • 0024596492 scopus 로고
    • Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis
    • COI: 1:CAS:528:DyaL1MXktlegs7s%3D, PID: 2542370
    • Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB (1989) Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol 23:73–81
    • (1989) J Neuroimmunol , vol.23 , pp. 73-81
    • Lyman, W.D.1    Sonett, J.R.2    Brosnan, C.F.3    Elkin, R.4    Bornstein, M.B.5
  • 46
    • 0034662868 scopus 로고    scopus 로고
    • The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
    • COI: 1:CAS:528:DC%2BD3cXmtVensbs%3D, PID: 10920191
    • Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 97:9561–9566
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 9561-9566
    • Malfait, A.M.1    Gallily, R.2    Sumariwalla, P.F.3    Malik, A.S.4    Andreakos, E.5    Mechoulam, R.6    Feldmann, M.7
  • 48
    • 84863979575 scopus 로고    scopus 로고
    • Disease modifying drugs in multiple sclerosis: mechanisms of action and new drugs in the horizon.CNSNeurolDisord Drug
    • COI: 1:CAS:528:DC%2BC38XhtF2jurvI
    • Marta M, Giovannoni G (2012) Disease modifying drugs in multiple sclerosis: mechanisms of action and new drugs in the horizon.CNSNeurolDisord Drug. Targets 11:610–623
    • (2012) Targets , vol.11 , pp. 610-623
    • Marta, M.1    Giovannoni, G.2
  • 49
    • 84939877387 scopus 로고    scopus 로고
    • Complementary and alternative medicine use and nutrient intake among individuals with multiple sclerosis in the United States
    • Masullo L, Papas MA, Cotugna N, Baker S, Mahoney L, Trabulsi J (2015) Complementary and alternative medicine use and nutrient intake among individuals with multiple sclerosis in the United States. J Community Health. Jul 1.2014 [Epub ahead of print]
    • (2015) J Community Health. Jul , vol.2014 , Issue.[Epub ahead of print] , pp. 1
    • Masullo, L.1    Papas, M.A.2    Cotugna, N.3    Baker, S.4    Mahoney, L.5    Trabulsi, J.6
  • 50
    • 84863468579 scopus 로고    scopus 로고
    • Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
    • COI: 1:STN:280:DC%2BC38jlsVOjug%3D%3D, PID: 22739983
    • Mecha M, Torrao AS, Mestre L, Carrillo-Salinas FJ, Mechoulam R, Guaza C (2012) Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death Dis 3:e331
    • (2012) Cell Death Dis , vol.3 , pp. e331
    • Mecha, M.1    Torrao, A.S.2    Mestre, L.3    Carrillo-Salinas, F.J.4    Mechoulam, R.5    Guaza, C.6
  • 51
    • 84882783935 scopus 로고    scopus 로고
    • Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors
    • COI: 1:CAS:528:DC%2BC3sXhsVylsbjK, PID: 23851307
    • Mecha M, Feliú A, Iñigo PM, Mestre L, Carrillo-Salinas FJ, Guaza C (2013) Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol Dis 59:141–150
    • (2013) Neurobiol Dis , vol.59 , pp. 141-150
    • Mecha, M.1    Feliú, A.2    Iñigo, P.M.3    Mestre, L.4    Carrillo-Salinas, F.J.5    Guaza, C.6
  • 52
    • 0036838389 scopus 로고    scopus 로고
    • Cannabidiol: an overview of some pharmacological aspects
    • COI: 1:CAS:528:DC%2BD38XoslKktrc%3D, PID: 12412831
    • Mechoulam R, Parker LA, Gallily R (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42(11 Suppl):11S–19S
    • (2002) J Clin Pharmacol , vol.42 , pp. 11S-19S
    • Mechoulam, R.1    Parker, L.A.2    Gallily, R.3
  • 54
    • 84893464528 scopus 로고    scopus 로고
    • Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis
    • COI: 1:CAS:528:DC%2BC2cXjsVWrsLg%3D, PID: 24440366
    • Musella A, Sepman H, Mandolesi G, Gentile A, Fresegna D, Haji N, Conrad A, Lutz B, Maccarrone M, Centonze D (2014) Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis. Neuropharmacology 79:567–572
    • (2014) Neuropharmacology , vol.79 , pp. 567-572
    • Musella, A.1    Sepman, H.2    Mandolesi, G.3    Gentile, A.4    Fresegna, D.5    Haji, N.6    Conrad, A.7    Lutz, B.8    Maccarrone, M.9    Centonze, D.10
  • 58
    • 0022556724 scopus 로고
    • 3H]Batrachotoxinin A 20-alpha-benzoate binding to sodium channels in rat brain: characterization and pharmacological significance
    • COI: 1:CAS:528:DyaL28Xkslanuro%3D, PID: 2426120
    • 3H]Batrachotoxinin A 20-alpha-benzoate binding to sodium channels in rat brain: characterization and pharmacological significance. Eur J Pharmacol 124:291–298
    • (1986) Eur J Pharmacol , vol.124 , pp. 291-298
    • Pauwels, P.J.1    Leysen, J.E.2    Laduron, P.M.3
  • 59
    • 33847119449 scopus 로고    scopus 로고
    • Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors
    • COI: 1:CAS:528:DC%2BD2sXhvVeltrk%3D, PID: 17220914
    • Pryce G, Baker D (2007) Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors. Br J Pharmacol 150:519–525
    • (2007) Br J Pharmacol , vol.150 , pp. 519-525
    • Pryce, G.1    Baker, D.2
  • 62
    • 84887606588 scopus 로고    scopus 로고
    • herapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis
    • COI: 1:CAS:528:DC%2BC3sXhsFOns7zJ, PID: 24036373
    • Ribeiro R, Yu F, Wen J, Vana A, Zhang Y (2013) herapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis. Neuroscience 254:427–442
    • (2013) Neuroscience , vol.254 , pp. 427-442
    • Ribeiro, R.1    Yu, F.2    Wen, J.3    Vana, A.4    Zhang, Y.5
  • 66
    • 28844489930 scopus 로고    scopus 로고
    • A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
    • COI: 1:CAS:528:DC%2BD2MXhtlSjsbnJ, PID: 16209908
    • Russo E, Guy GW (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 66:234–246
    • (2006) Med Hypotheses , vol.66 , pp. 234-246
    • Russo, E.1    Guy, G.W.2
  • 67
    • 60849124534 scopus 로고    scopus 로고
    • Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels
    • COI: 1:CAS:528:DC%2BD1MXisV2hurw%3D, PID: 19228959
    • Ryan D, Drysdale AJ, Lafourcade C, Pertwee RG, Platt B (2009) Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci 29:2053–2063
    • (2009) J Neurosci , vol.29 , pp. 2053-2063
    • Ryan, D.1    Drysdale, A.J.2    Lafourcade, C.3    Pertwee, R.G.4    Platt, B.5
  • 69
    • 84885137892 scopus 로고    scopus 로고
    • Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis
    • COI: 1:CAS:528:DC%2BC3sXhs1egs7rK, PID: 24130809
    • Sisay S, Pryce G, Jackson SJ, Tanner C, Ross RA, Michael GJ, Selwood DL, Giovannoni G, Baker D (2013) Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. PLoS One 8(10):e76907
    • (2013) PLoS One , vol.8 , Issue.10 , pp. e76907
    • Sisay, S.1    Pryce, G.2    Jackson, S.J.3    Tanner, C.4    Ross, R.A.5    Michael, G.J.6    Selwood, D.L.7    Giovannoni, G.8    Baker, D.9
  • 70
    • 33847653702 scopus 로고    scopus 로고
    • Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
    • COI: 1:CAS:528:DC%2BD2sXisVeis7Y%3D, PID: 17245363
    • Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150:613–623
    • (2007) Br J Pharmacol , vol.150 , pp. 613-623
    • Thomas, A.1    Baillie, G.L.2    Phillips, A.M.3    Razdan, R.K.4    Ross, R.A.5    Pertwee, R.G.6
  • 71
    • 39149092685 scopus 로고    scopus 로고
    • Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol
    • COI: 1:CAS:528:DC%2BD1cXisVWiu7c%3D, PID: 18206320
    • Vann RE, Gamage TF, Warner JA, Marshall EM, Taylor NL, Martin BR, Wiley JL (2008) Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug Alcohol Depend 94:191–198
    • (2008) Drug Alcohol Depend , vol.94 , pp. 191-198
    • Vann, R.E.1    Gamage, T.F.2    Warner, J.A.3    Marshall, E.M.4    Taylor, N.L.5    Martin, B.R.6    Wiley, J.L.7
  • 72
    • 33646558622 scopus 로고    scopus 로고
    • Interactions between Δ9-THC and cannabidiol in mouse models of cannabinoid activity
    • COI: 1:CAS:528:DC%2BD28Xks1emurg%3D, PID: 16572263
    • Varvel SA, Wiley JL, Yang R, Bridgen DT, Long K, Lichtman AH, Martin BR (2006) Interactions between Δ9-THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology 186:226–234
    • (2006) Psychopharmacology , vol.186 , pp. 226-234
    • Varvel, S.A.1    Wiley, J.L.2    Yang, R.3    Bridgen, D.T.4    Long, K.5    Lichtman, A.H.6    Martin, B.R.7
  • 73
    • 0345669751 scopus 로고    scopus 로고
    • A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
    • PID: 12617376
    • Wade DT, Robson P, House H, Makela P, Aram J (2003) A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 17:21–219
    • (2003) Clin Rehabil , vol.17 , pp. 21-219
    • Wade, D.T.1    Robson, P.2    House, H.3    Makela, P.4    Aram, J.5
  • 74
    • 0036017498 scopus 로고    scopus 로고
    • Sodium channels as molecular targets in multiple sclerosis
    • PID: 12051467
    • Waxman SG (2002) Sodium channels as molecular targets in multiple sclerosis. J Rehabil Res Dev 39:233–242
    • (2002) J Rehabil Res Dev , vol.39 , pp. 233-242
    • Waxman, S.G.1
  • 75
    • 44649195035 scopus 로고    scopus 로고
    • Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis
    • COI: 1:CAS:528:DC%2BD1cXmvVOms7k%3D, PID: 18501510
    • Webb M, Luo L, Ma JY, Tham CS (2008) Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis. Neurosci Lett 439:106–110
    • (2008) Neurosci Lett , vol.439 , pp. 106-110
    • Webb, M.1    Luo, L.2    Ma, J.Y.3    Tham, C.S.4
  • 77
    • 84898720683 scopus 로고    scopus 로고
    • Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology
    • PID: 24663230
    • Yadav V, Bever C Jr, Bowen J, Bowling A, Weinstock-Guttman B, Cameron M, Bourdette D, Gronseth GS, Narayanaswami P (2014) Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 82:1083–1092
    • (2014) Neurology , vol.82 , pp. 1083-1092
    • Yadav, V.1    Bever, C.2    Bowen, J.3    Bowling, A.4    Weinstock-Guttman, B.5    Cameron, M.6    Bourdette, D.7    Gronseth, G.S.8    Narayanaswami, P.9
  • 78
    • 0242654882 scopus 로고    scopus 로고
    • Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
    • COI: 1:CAS:528:DC%2BD3sXovVWlsr0%3D, PID: 14615106
    • Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A, UK MS Research Group (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 362:1517–1526
    • (2003) Lancet , vol.362 , pp. 1517-1526
    • Zajicek, J.1    Fox, P.2    Sanders, H.3    Wright, D.4    Vickery, J.5    Nunn, A.6    Thompson, A.7
  • 80
    • 84867402348 scopus 로고    scopus 로고
    • Multiple sclerosis and extract of cannabis: results of the MUSEC trial.J NeurolNeurosurg
    • Zajicek JP, Hobart JC, Slade A, Barnes D, Mattison PG, MUSEC Research Group (2012) Multiple sclerosis and extract of cannabis: results of the MUSEC trial.J NeurolNeurosurg. Psychiatry 83:1125–1132
    • (2012) Psychiatry , vol.83 , pp. 1125-1132
    • Zajicek, J.P.1    Hobart, J.C.2    Slade, A.3    Barnes, D.4    Mattison, P.G.5
  • 81
    • 84881556664 scopus 로고    scopus 로고
    • Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
    • COI: 1:CAS:528:DC%2BC3sXhtFSmurjE, PID: 23856559
    • Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Gomez Cano M, McManus D, Mallik S, Hobart J, CUPID investigator group (2013) Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. Lancet Neurol 12:857–865
    • (2013) Lancet Neurol , vol.12 , pp. 857-865
    • Zajicek, J.1    Ball, S.2    Wright, D.3    Vickery, J.4    Nunn, A.5    Miller, D.6    Gomez Cano, M.7    McManus, D.8    Mallik, S.9    Hobart, J.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.